Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Japanese Journal of Radiology
Erschienen in: Japanese Journal of Radiology 10/2019

01.08.2019 | Invited Review

Early detection of intrahepatic cholangiocarcinoma

verfasst von: Mami Hamaoka, Kazuto Kozaka, Osamu Matsui, Takahiro Komori, Takashi Matsubara, Norihide Yoneda, Kotaro Yoshida, Dai Inoue, Azusa Kitao, Wataru Koda, Toshifumi Gabata, Satoshi Kobayashi

Erschienen in: Japanese Journal of Radiology | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Cholangiocarcinoma (CC) is a malignant tumor which arises from the biliary epithelium and most cases represent adenocarcinoma. CC can be classified into intrahepatic CC (ICC), perihilar CC, and distal CC, based on the site of anatomic origin. The incidence of ICC is increasing in both Western and Eastern countries, while that of extrahepatic cholangiocarcinoma remains fairly stable. ICC infiltrates into adjacent nerves and lymphatic vessels, resulting in progressive disease with a poor prognosis; thus, early detection of ICC is critical for achieving better outcomes and providing better patient care. However, it is difficult for clinicians to detect an ICC, especially in its early stage. Different from hepatocellular carcinoma, the lack of surveillance system for the high-risk group of CC does not allow for a reliable screening examination. In this context, for early detection and diagnosis of ICC, radiologists need to know predisposing conditions that can lead to the development of ICC, such as chronic biliary or hepatic inflammation, primary sclerosing cholangitis, congenital biliary diseases, and other conditions. In this article, we discuss and illustrate the radiologic features of ICC with special attention to early disease stages and of predisposing conditions of ICC.
Literatur
1.
T. Bosman FC, Ralph H. Hruban, Neil D. Theise. WHO classification of tumours of the digestive system 2010.
2.
Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29(2):221–32.CrossRefPubMed
3.
4.
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–2.CrossRefPubMed
5.
Shimonishi T, Sasaki M, Nakanuma Y. Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2000;7(6):542–50.CrossRef
6.
Aishima S, Oda Y. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci. 2015;22(2):94–100.CrossRefPubMed
7.
Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69–766.CrossRefPubMedPubMedCentral
8.
Joo I, Lee JM. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging. 2013;38(6):1334–500.CrossRefPubMed
9.
Desmet VJ. East-West pathology agreement on precancerous liver lesions and early hepatocellular carcinoma. Hepatology. 2009;49(2):355–7.CrossRefPubMed
10.
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC Cancer Staging Manual. 8th ed. Springer: American Joint Commission on Cancer; 2017.
11.
Brierley JD. TNM classification of malignant tumours. New York: Wiley; 2017.
12.
Japan LCSGO. The general rules for the clinical and pathological study of primary liver cancer (Japanese). 5th ed. Tokyo: Kanehara; 2015.
13.
Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007;20(6):701–9.CrossRefPubMed
14.
Nakanuma Y, Sasaki M, Sato Y, Ren X, Ikeda H, Harada K. Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. World J Hepatol. 2009;1(1):35–42.CrossRefPubMedPubMedCentral
15.
Aishima S, Nishihara Y, Tsujita E, Taguchi K, Soejima Y, Taketomi A, et al. Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia. Hum Pathol. 2008;39(6):939–47.CrossRefPubMed
16.
Nakanuma Y, Curado M-P, Franceschi S, Gores G, Paradis V, Sripa B, et al. Intrahepatic cholangiocarcinoma. 4th ed. Lyon: IARC; 2010.
17.
Nakanuma Y, Sato Y, Ojima H, Kanai Y, Aishima S, Yamamoto M, et al. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)". Int J Clin Exp Pathol. 2014;7(6):3112–22.PubMedPubMedCentral
18.
Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology. 2000;31(1):12–7.CrossRefPubMed
19.
Nakanuma Y. A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int. 2010;60(6):419–29.CrossRefPubMed
20.
Rocha FG, Lee H, Katabi N, DeMatteo RP, Fong Y, Dangelica MI, et al. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology. 2012;56(4):1352–60.CrossRefPubMed
21.
Fujikura K, Fukumoto T, Ajiki T, Otani K, Kanzawa M, Akita M, et al. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas. Histopathology. 2016;69(6):950–61.CrossRefPubMed
22.
Lim JH, Zen Y, Jang KT, Kim YK, Nakanuma Y. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects. AJR Am J Roentgenol. 2011;197(5):1111–20.CrossRefPubMed
23.
Lim JH, Jang K-T, Choi D. Biliary intraductal papillary-mucinous neoplasm manifesting only as dilatation of the hepatic lobar or segmental bile ducts: imaging features in six patients. Am J Roentgenol. 2008;191(3):778–82.CrossRef
24.
Takanami K, Yamada T, Tsuda M, Takase K, Ishida K, Nakamura Y, et al. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging. 2011;36(4):447–56.CrossRefPubMed
25.
Jung AY, Lee JM, Choi SH, Kim SH, Lee JY, Kim SW, et al. CT features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr. 2006;30(2):173–81.CrossRefPubMed
26.
Komori T, Inoue D, Zen Y, Yoneda N, Kitao A, Kozaka K, et al. CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas. Eur Radiol. 2019;29(6):3132–40.CrossRefPubMed
27.
Chung DJ, Lee SK, Ha HK, Kim PN, Lee M-G. Multiple biliary papillomatosis: comparison of MR cholangiography with endoscopic retrograde cholangiography. J Comput Assist Tomogr. 2002;26(6):968–74.CrossRefPubMed
28.
Yoon HJ, Kim YK, Jang K-T, Lee KT, Lee JK, Choi DW, et al. Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI. Abdom Imaging. 2013;38(5):1082–90.CrossRefPubMed
29.
Kubo M, Sakamoto M, Fukushima N, Yachida S, Nakanishi Y, Shimoda T, et al. Less aggressive features of colorectal cancer with liver metastases showing macroscopic intrabiliary extension. Pathol Int. 2002;52(8):514–8.CrossRefPubMed
30.
Gabata T, Kadoya M, Matsui O, Kobayashi T, Sanada J, Mori A. Intrahepatic biliary calculi: correlation of unusual MR findings with pathologic findings. Abdom Imaging. 2000;25(3):266–8.CrossRefPubMed
31.
Nakanishi Y, Nakanuma Y, Ohara M, Iwao T, Kimura N, Ishidate T, et al. Intraductal papillary neoplasm arising from peribiliary glands connecting with the inferior branch of the bile duct of the anterior segment of the liver. Pathol Int. 2011;61(12):773–7.CrossRefPubMed
32.
Zen Y, Jang KT, Ahn S, Kim DH, Choi DW, Choi SH, et al. Intraductal papillary neoplasms and mucinous cystic neoplasms of the hepatobiliary system: demographic differences between Asian and Western populations, and comparison with pancreatic counterparts. Histopathology. 2014;65(2):164–73.CrossRefPubMed
33.
Zen Y, Pedica F, Patcha VR, Capelli P, Zamboni G, Casaril A, et al. Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol. 2011;24(8):1079–89.CrossRefPubMed
34.
Mortele KJ, Ros PR. Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics. 2001;21(4):895–910.CrossRefPubMed
35.
Shiono S, Suda K, Nobukawa B, Arakawa A, Yamasaki S, Sasahara N, et al. Pancreatic, hepatic, splenic, and mesenteric mucinous cystic neoplasms (MCN) are lumped together as extra ovarian MCN. Pathol Int. 2006;56(2):71–7.CrossRefPubMed
36.
Kovacs MD, Sheafor DH, Burchett PF, Picard MM, Hardie AD. Differentiating biliary cystadenomas from benign hepatic cysts: preliminary analysis of new predictive imaging features. Clin Imaging. 2018;49:44–7.CrossRefPubMed
37.
Lim JH, Jang KT, Choi D, Lee WJ, Lim HK. Early bile duct carcinoma: comparison of imaging features with pathologic findings. Radiology. 2006;238(2):542–8.CrossRefPubMed
38.
Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg. 2003;10(4):288–91.CrossRefPubMed
39.
Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H. Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol. 2010;2(12):419–27.CrossRefPubMedPubMedCentral
40.
Cardinale V, Semeraro R, Torrice A, Gatto M, Napoli C, Bragazzi MC, et al. Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors. World J Gastrointest Oncol. 2010;2(11):407–16.CrossRefPubMedPubMedCentral
41.
Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol. 2003;181(3):819–27.CrossRefPubMed
42.
Kozaka K, Sasaki M, Fujii T, Harada K, Zen Y, Sato Y, et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Histopathology. 2007;51(3):390–400.CrossRefPubMed
43.
Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, et al. Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns. Am J Surg Pathol. 2018;42(10):1334–455.CrossRefPubMedPubMedCentral
44.
Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol. 2007;189(6):1428–34.CrossRefPubMed
45.
Kim SA, Lee JM, Lee KB, Kim SH, Yoon SH, Han JK, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic ct, with special emphasis on arterial enhancement pattern-correlation with clinicopathologic findings. Radiology. 2011;260(1):148–57.CrossRefPubMed
46.
Razumilava N, Gores GJ (2013) Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol 11(1), 13–21 (e1; quiz e3–4).
47.
Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics. 2009;29(2):385–402.CrossRefPubMed
48.
Nishie A, Yoshimitsu K, Asayama Y, Irie H, Aibe H, Tajima T, et al. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings. AJR Am J Roentgenol. 2005;184(4):1157–62.CrossRefPubMed
49.
Yoshida K, Kobayashi S, Matsui O, Gabata T, Sanada J, Koda W, et al. Hepatic pseudolymphoma: imaging-pathologic correlation with special reference to hemodynamic analysis. Abdom Imaging. 2013;38(6):1277–85.CrossRefPubMed
50.
Park HS, Lee JM, Kim SH, Jeong JY, Kim YJ, Lee KH, et al. CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis. AJR Am J Roentgenol. 2006;187(2):445–53.CrossRefPubMed
51.
Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdom Imaging. 2004;29(5):540–7.PubMed
52.
Han JK, Lee JM. Intrahepatic intraductal cholangiocarcinoma. Abdom Imaging. 2004;29(5):558–64.CrossRefPubMed
53.
Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683–700.CrossRefPubMed
54.
Kim JH, Byun JH, Lee SJ, Park SH, Kim HJ, Lee SS, et al. Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography. Eur Radiol. 2012;22(11):2502–13.CrossRefPubMed
55.
Khaderi SA, Sussman NL. Screening for malignancy in primary sclerosing cholangitis (PSC). Curr Gastroenterol Rep. 2015;17(4):1–5.CrossRef
56.
Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004;233(1):234–40.CrossRefPubMed
57.
58.
Ettel M, Eze O, Xu R. Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma. World J Hepatol. 2015;7(25):2563–70.CrossRefPubMedPubMedCentral
59.
Tazuma S. Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20(6):1075–83.CrossRefPubMed
60.
Tabrizian P, Jibara G, Shrager B, Schwartz ME, Roayaie S. Hepatic resection for primary hepatolithiasis: a single-center Western experience. J Am Coll Surg. 2012;215(5):622–6.CrossRefPubMed
61.
Catena M, Aldrighetti L, Finazzi R, Arzu G, Arru M, Pulitano C, et al. Treatment of non-endemic hepatolithiasis in a Western country: the role of hepatic resection. Ann R Coll Surg Engl. 2006;88(4):383–9.CrossRefPubMedPubMedCentral
62.
Tazuma S, Unno M, Igarashi Y, Inui K, Uchiyama K, Kai M, et al. Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 2017;52(3):276–300.CrossRefPubMed
63.
Singh A, Mann HS, Thukral CL, Singh NR. Diagnostic accuracy of MRCP as compared to ultrasound/CT in patients with obstructive jaundice. J Clin Diagn Res. 2014;8(3):103–7.PubMedPubMedCentral
64.
Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, Chintapalli KN. Mimics of cholangiocarcinoma: spectrum of disease. Radiographics. 2008;28(4):1115–29.CrossRefPubMed
65.
66.
Choi D, Lim J, Hong S-T. Relation of cholangiocarcinomas to clonorchiasis and bile duct stones. Abdom Imaging. 2004;29(5):590–7.PubMed
67.
Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme “ductal plate malformation”. Hepatology. 1992;16(4):1069–83.CrossRefPubMed
68.
Kim HJ, Kim JS, Joo MK, Lee BJ, Kim JH, Yeon JE, et al. Hepatolithiasis and intrahepatic cholangiocarcinoma: a review. World J Gastroenterol. 2015;21(48):13418–31.CrossRefPubMedPubMedCentral
69.
Levy AD, Rohrmann CA Jr, Murakata LA, Lonergan GJ. Caroli's disease: radiologic spectrum with pathologic correlation. AJR Am J Roentgenol. 2002;179(4):1053–7.CrossRefPubMed
70.
Song JS, Lee YJ, Kim KW, Huh J, Jang SJ, Yu E. Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases. Pathol Int. 2008;58(8):503–12.CrossRefPubMed
71.
Watanabe Y, Toki A, Todani T. Bile duct cancer developed after cyst excision for choledochal cyst. J Hepatobiliary Pancreat Sci. 1999;6(3):207–12.CrossRef
72.
Tatekawa Y, Asonuma K, Uemoto S, Inomata Y, Tanaka K. Liver transplantation for biliary atresia associated with malignant hepatic tumors. J Pediatr Surg. 2001;36(3):436–9.CrossRefPubMed
73.
Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011;54(5):1842–52.CrossRefPubMed
74.
Dave M, Elmunzer BJ, Dwamena BA, Higgins PD. Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography 1. Radiology. 2010;256(2):387–96.CrossRefPubMed
75.
Lee JJ, Schindera ST, Jang HJ, Fung S, Kim TK. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis. Abdom Radiol (NY). 2017;42(12):2898–908.CrossRefPubMed
76.
Vitellas KM, Keogan MT, Freed KS, Enns RA, Spritzer CE, Baillie JM, et al. radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography 1. Radiographics. 2000;20(4):959–75.CrossRefPubMed
77.
Elsayes KM, Oliveira EP, Narra VR, Abou-El-Abbass HA, Ahmed MI, Tongdee R, et al. MR and MRCP in the evaluation of primary sclerosing cholangitis: current applications and imaging findings. J Comput Assist Tomogr. 2006;30(3):398–404.CrossRefPubMed
78.
Ni Mhuircheartaigh JM, Lee KS, Curry MP, Pedrosa I, Mortele KJ. Early peribiliary hyperenhancement on MRI in patients with primary sclerosing cholangitis: significance and association with the Mayo risk score. Abdom Radiol (NY). 2017;42(1):152–8.CrossRefPubMed
79.
Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, et al. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology. 1998;28(3):700–6.CrossRefPubMed
80.
Prytz H, Keiding S, Björnsson E, Broomé U, Almer S, Castedal M, et al. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology. 2006;44(6):1572–80.CrossRefPubMed
81.
82.
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. The Lancet. 2005;366(9493):1303–14.CrossRef
83.
Lim JH, Kim YI, Park CK. Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver. Abdom Imaging. 2000;25(1):89–92.CrossRefPubMed
84.
Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev. 2004;17(3):540–52.CrossRefPubMedPubMedCentral
85.
Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5(10):1221–8.CrossRefPubMedPubMedCentral
86.
Sørensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjær L, Linet M, et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology. 1998;28(4):921–5.CrossRefPubMed
87.
Shen W-F, Zhong W, Xu F, Kan T, Geng L, Xie F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol. 2009;15(47):5976–82.CrossRefPubMedPubMedCentral
88.
Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, et al. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol. 2007;31(7):1059–67.CrossRefPubMed
89.
Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis. Cancer. 2000;88(11):2471–7.CrossRefPubMed
90.
Sahani D, Prasad S, Tannabe K, Hahn P, Mueller P, Saini S. Thorotrast-induced cholangiocarcinoma: case report. Abdom Imaging. 2003;28(1):0072–74.CrossRef
91.
National Research Council. Effects on Populations of Exposure to Low Levels of Ionizing Radiation. Washington, DC: The National Academies Press; 1980.
92.
Hardell L, Bengtsson N, Jonsson U, Eriksson S, Larsson L. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria–an epidemiological investigation. Br J Cancer. 1984;50(3):389.CrossRefPubMedPubMedCentral
93.
94.
Kim YS, Rha SE, Oh SN, Jung SE, Shin YR, Choi BG, et al. Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol. 2010;11(5):560–5.CrossRefPubMedPubMedCentral
95.
Gore RM, Levine MS. Textbook of gastrointestinal radiology. Philadelphia: Elsevier Health Sciences; 2014.
96.
Hughes NR, Goodman ZD, Bhathal PS. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis. Am J Surg Pathol. 2010;34(9):1312–8.CrossRefPubMed
97.
Kim YS, Rha SE, Oh SN, Jung SE, Shin YR, Choi BG, et al. Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol. 2010;11(5):560–5.CrossRefPubMedPubMedCentral
98.
Tajima T, Honda H, Kuroiwa T, Yoshimitsu K, Irie H, Aibe H, et al. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver. J Comput Assist Tomogr. 1999;23(5):690–5.CrossRefPubMed
99.
Chuy JA, Garg I, Graham RP, VanBuren WM, Venkatesh SK. Imaging features of bile duct adenoma: case series and review of literature. Diagn Interv Radiol. 2018;24(5):249–54.CrossRefPubMedPubMedCentral
100.
Azizah N, Paradinas FJ. Cholangiocarcinoma coexisting with developmental liver cysts: a distinct entity different from liver cystadenocarcinoma. Histopathology. 1980;4(4):391–400.CrossRefPubMed
101.
Lin C-C, Lin S-C, Ko W-C, Chang K-M, Shih S-C. Adenocarcinoma and infection in a solitary hepatic cyst: a case report. World J Gastroenterol WJG. 2005;11(12):1881.CrossRefPubMed
Metadaten
Titel
Early detection of intrahepatic cholangiocarcinoma
verfasst von
Mami Hamaoka
Kazuto Kozaka
Osamu Matsui
Takahiro Komori
Takashi Matsubara
Norihide Yoneda
Kotaro Yoshida
Dai Inoue
Azusa Kitao
Wataru Koda
Toshifumi Gabata
Satoshi Kobayashi
Publikationsdatum
01.08.2019
Verlag
Springer Japan
Erschienen in
Japanese Journal of Radiology / Ausgabe 10/2019
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-019-00860-0

Weitere Artikel der Ausgabe 10/2019

Japanese Journal of Radiology 10/2019 Zur Ausgabe

Original Article

In vitro evaluation of radiopacity of contrast-loaded superabsorbent polymer microspheres (SAP-MS) with static imaging and flow model

Original Article

Whole-tumor histogram analysis of DWI and QSI for differentiating between meningioma and schwannoma: a pilot study

Original Article

Factors affecting the accuracy of respiratory tracking of the image-guided robotic radiosurgery system

Original Article

Management of acute cholecystitis after biliary stenting for malignant obstruction: comparison of percutaneous gallbladder drainage and aspiration

Invited Review

MRI-detected breast lesions: clinical implications and evaluation based on MRI/ultrasonography fusion technology

Original Article

Assessment of angiogenesis in rabbit orthotropic liver tumors using three-dimensional dynamic contrast-enhanced ultrasound compared with two-dimensional DCE-US

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

S3-Leitlinie zu Pankreaskrebs aktualisiert

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet
weitere anzeigen

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen